| 4.86 Data as of May 24 | -0.11 / -2.21%Today’s Change | 3.68 Today|||52-Week Range 7.58 | +12.76% Year-to-Date |
The 1 analysts offering 12-month price forecasts for SciClone Pharmaceuticals Inc have a median target of 8.25, with a high estimate of 8.25 and a low estimate of 8.25. The median estimate represents a +69.75% increase from the last price of 4.86.

The current consensus among 2 polled investment analysts is to Outperform stock in SciClone Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




